Carisma Therapeutics Receives FDA Clearance of Investigational New Drug Application for CT-0525, a Novel CAR-M Cell Therapy
Having received a Study May Proceed notification from the FDA, Carisma plans to initiate a Phase 1 study in the months to come and to treat the first patient in the first half of 2024.
Penn’s Leadership Role in Philadelphia’s Rapidly Growing Life Sciences Industry Highlighted
Technical.ly published an article about the future of the growth of the life sciences in Philadelphia, highlighting Penn’s role in the development of the city as a strong tech hub.
Gov. Josh Shapiro, President Liz Magill, and others from the Penn community Celebrate the new Penn Institute for RNA Innovation
“One of our great strategic advantages is our compact and contiguous campus, where 12 amazing schools and a world-class health system coexist just a short walk from one another,” said Magill.
Mitchell Lab: Lipid nanoparticles that deliver mRNA to T cells show potential treatment for autoimmune diseases
The goal of this platform is to engineer adoptive cell therapies inside of the body for specific autoimmune diseases.
Cabaletta Bio Receives Another FDA Clearance for IND application of CABA-201
The company plans to initiate a Phase 1/2 clinical trial of CABA-201 in two cohorts of patients with generalized myasthenia gravis (gMG).
Vetigenics’ Treats its First Canine Cancer Patient
Vetigenics announced that the first canine patient has received his first dose of Vetigenics' fully canine anti-CTLA4 monoclonal antibody (VGS-001) for oral melanoma.
Emily Whitehead, the first child to be cured of cancer with Penn-invented CAR-T therapy, is now a freshman at Penn
From American Sign Language to English to nature photography, Emily has a wide range of interests she intends to explore in her studies.
Penn spinout Interius Biotherapeutics raises another $21.5M
Co-founded by Saar Gill, MD, PhD, Interius is developing a new platform for cell-specific gene delivery in patients.
Penn Faculty Discover An Innovative Potential Treatment for Tooth Decay
In search of a more effective treatment, the research team employed a combination of ferumoxytol (Fer) and stannous fluoride (SnF2) to fight tooth decay.
National Academy of Medicine Elects Five Penn Experts
Five Penn experts have been elected to the National Academy of Medicine (NAM), one of the nation’s highest honors in the fields of health and medicine.